CompletedNot Applicable

Effects of Abdominal Exercises and Kinesio Taping on Abdominal Strength in Females With Diastasis Recti.

Pakistan38 participantsStarted 2022-11-20

Plain-language summary

Diastasis recti is an increase in the gap between the rectus abdominis muscles at the midline caused by anterior abdominal wall weakening. The aim of this study is to evaluate the effects of abdominal exercises with and without Kinesio taping on abdominal strength of females with diastasis recti for their better quality of life. This study will be randomized controlled trial .Subjects with diastasis recti meeting the predetermined inclusion and exclusion criteria will be requested to participate in the study via informed consent. Non probability convenient sampling technique will be used. 46 participants will be randomly allocated to either Group A or Group B .Group A will be treated with Kinesio Taping applied in a criss -cross design for consecutive 3 days with 1 day gap after taping will do abdominal exercises.Group B will be treated with above mentioned abdominal exercises for 1 month. Pre and post assessment of diastasis recti and abdominal strength will be done using caliper method and manual muscle test and quality of life will be assessed by MAPP-QOL questionnaire.Jinnah Hospital will be the setting and SPSS software will be used.

Who can participate

Age range

18 Years – 40 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Post natal till 6 months * Rectus abdominis diastasis \> 2.7 cm at umbilicus * Age 18 to 40 Exclusion Criteria: * Pregnant female * Hernia * Females with physical and mental illness * Females with any other medical condition like cardiorespiratory diseases * History of malignancy * Urogynecologic disorders * Females suffering from other gynecological issues such as endometriosis * Polycystic ovaries syndrome

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Caliper Method

Timeframe: 4 weeks

MMT

Timeframe: 4weeks

MAPP QOL

Timeframe: 4 weeks

Trial details

NCT IDNCT05811299

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

View on ClinicalTrials.gov More Diastasis Recti trials